Anne-Sophie Rebillat
Overview
Explore the profile of Anne-Sophie Rebillat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
369
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flores-Aguilar L, Hamlett E, Araya P, Barone E, Bhattacharyya A, Carmona-Iragui M, et al.
Neuromolecular Med
. 2025 Jan;
27(1):5.
PMID: 39756004
Down syndrome (DS) or trisomy 21 (T21) is present in a significant number of children and adults around the world and is associated with cognitive and medical challenges. Through research,...
2.
Larsen F, Baksh R, McGlinchey E, Langballe E, Benejam B, Beresford-Webb J, et al.
Alzheimers Dement
. 2024 Mar;
20(5):3270-3280.
PMID: 38506627
Introduction: People with Down syndrome (DS) have high risk of developing Alzheimer's disease (AD). This study examined mean ages of AD diagnosis and associations with co-occurring conditions among adults with...
3.
Hamlett E, Flores-Aguilar L, Handen B, Potier M, Granholm A, Sherman S, et al.
Mol Syndromol
. 2023 Apr;
14(2):89-100.
PMID: 37064334
Research focused on Down syndrome continued to gain momentum in the last several years and is advancing our understanding of how trisomy 21 (T21) modifies molecular and cellular processes. The...
4.
Malle L, Patel R, Martin-Fernandez M, Stewart O, Philippot Q, Buta S, et al.
Nature
. 2023 Feb;
615(7951):305-314.
PMID: 36813963
Down's syndrome (DS) presents with a constellation of cardiac, neurocognitive and growth impairments. Individuals with DS are also prone to severe infections and autoimmunity including thyroiditis, type 1 diabetes, coeliac...
5.
Pinku H, Huls A, Feany P, Baumer N, Dierssen M, Bargagna S, et al.
J Glob Health
. 2022 Aug;
12:05035.
PMID: 35932238
Background: People with Down syndrome (DS) are one of the highest risk groups for mortality associated with COVID-19, but outcomes may differ across countries due to different co-morbidity profiles, exposures,...
6.
Moreau M, Carmona-Iragui M, Altuna M, Dalzon L, Barroeta I, Vilaire M, et al.
Biomedicines
. 2022 Jun;
10(6).
PMID: 35740400
Down syndrome (DS) is a complex genetic condition due to an additional copy of human chromosome 21, which results in the deregulation of many genes. In addition to the intellectual...
7.
Huls A, Feany P, Zisman S, Costa A, Dierssen M, Balogh R, et al.
Vaccines (Basel)
. 2022 Apr;
10(4).
PMID: 35455279
Individuals with Down syndrome (DS) are among the groups with the highest risk for severe COVID-19. Better understanding of the efficacy and risks of COVID-19 vaccines for individuals with DS...
8.
Emes D, Huls A, Baumer N, Dierssen M, Puri S, Russell L, et al.
J Clin Med
. 2021 Nov;
10(21).
PMID: 34768645
Adults with Down Syndrome (DS) are at higher risk for severe outcomes of coronavirus disease 2019 (COVID-19) than the general population, but evidence is required to understand the risks for...
9.
Rujeedawa T, Carrillo Felez E, Clare I, Fortea J, Strydom A, Rebillat A, et al.
J Clin Med
. 2021 Oct;
10(19).
PMID: 34640600
The purpose of this review is to compare and highlight the clinical and pathological aspects of genetic versus acquired Alzheimer's disease: Down syndrome-associated Alzheimer's disease in (DSAD) and Autosomal Dominant...
10.
Rebillat A, Hiance-Delahaye A, Falquero S, Radice G, Sacco S
Res Dev Disabil
. 2021 Sep;
118:104068.
PMID: 34467872
Background: People with Down Syndrome (DS) are at an increased risk of developing Alzheimer's Disease (AD) relatively early in life. The dementia screening questionnaire for individuals with intellectual disabilities (DSQIID)...